1. Home
  2. ORIC vs CIVB Comparison

ORIC vs CIVB Comparison

Compare ORIC & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • CIVB
  • Stock Information
  • Founded
  • ORIC 2014
  • CIVB 1884
  • Country
  • ORIC United States
  • CIVB United States
  • Employees
  • ORIC N/A
  • CIVB N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • CIVB Major Banks
  • Sector
  • ORIC Health Care
  • CIVB Finance
  • Exchange
  • ORIC Nasdaq
  • CIVB Nasdaq
  • Market Cap
  • ORIC 362.9M
  • CIVB 349.3M
  • IPO Year
  • ORIC 2020
  • CIVB N/A
  • Fundamental
  • Price
  • ORIC $8.17
  • CIVB $22.55
  • Analyst Decision
  • ORIC Strong Buy
  • CIVB Buy
  • Analyst Count
  • ORIC 8
  • CIVB 4
  • Target Price
  • ORIC $18.83
  • CIVB $25.67
  • AVG Volume (30 Days)
  • ORIC 1.6M
  • CIVB 39.8K
  • Earning Date
  • ORIC 05-05-2025
  • CIVB 04-24-2025
  • Dividend Yield
  • ORIC N/A
  • CIVB 3.02%
  • EPS Growth
  • ORIC N/A
  • CIVB N/A
  • EPS
  • ORIC N/A
  • CIVB 2.26
  • Revenue
  • ORIC N/A
  • CIVB $153,524,000.00
  • Revenue This Year
  • ORIC N/A
  • CIVB $17.44
  • Revenue Next Year
  • ORIC N/A
  • CIVB $5.37
  • P/E Ratio
  • ORIC N/A
  • CIVB $9.99
  • Revenue Growth
  • ORIC N/A
  • CIVB 2.34
  • 52 Week Low
  • ORIC $3.90
  • CIVB $13.60
  • 52 Week High
  • ORIC $14.67
  • CIVB $24.00
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 72.38
  • CIVB 51.98
  • Support Level
  • ORIC $5.52
  • CIVB $21.46
  • Resistance Level
  • ORIC $8.44
  • CIVB $23.66
  • Average True Range (ATR)
  • ORIC 0.63
  • CIVB 1.10
  • MACD
  • ORIC 0.32
  • CIVB -0.16
  • Stochastic Oscillator
  • ORIC 93.11
  • CIVB 42.91

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

Share on Social Networks: